Drug discovery remains a global endeavor requiring access to, and analyses of, more data than ever. Finding the right drug candidates at the optimal Intersection of target binding, bioavailability, pharmacological activity, safety, market access, and patient need is essential.
We develop products to streamline and simplify the work of biopharma professionals by harnessing AI and ML to process high volumes of data, automate tasks, increase accuracy, and secure competitive edge in today’s ever changing market.
Our products empower healthcare and life sciences companies to discover new links between data, uncover patterns and trends, detect anomalies, and predict likely outcomes.
Contextualize assay results in the context of known biomedical relationships
Advance and prioritize drug development pipelines
Support pathway analyses
Find partnerships and licensing opportunities with knowledge of the global pharmaceutical market
Discover gene-to-disease relationships for indication selection
Maintain competitive intelligence
ERGO, allows scientists to quickly discover new insights from exponentially growing biomedical datasets to make more informed decisions.
Cloud-scale bioinformatic and NLP solutions for faster drug development